Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Carbidopa and Levodopa Extended-Release Tablets, USP Rx only
Medication labelWhy this: Advisory · dailymed-prescription
Carbidopa and levodopa extended-release tablets, USP are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
- generic_name
- carbidopa and levodopa
- product_names
- Carbidopa and Levodopa
- ndc
- 0615-8460, 0615-8461, 50228-460, 0615-8460-39, 50228-461, 0615-8461-39
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en